ATRY Relative Valuation - Atrys Health SA

Watchlist Manager

Watchlist

Price: 2.71 EUR -1.09% Market Closed

Market Cap: €206m

A	Atrys Health SA MAD:ATRY	ES
	American Well Corp NYSE:AMWL	US
	Daegu Department Store Co Ltd KRX:006370	KR
	Fulgent Sun International (Holding) Co Ltd TWSE:9802	TW
	Victoria Oil & Gas PLC LSE:VOG	UK
	Raghav Productivity Enhancers Ltd BSE:539837	IN
	Equity Residential NYSE:EQR	US

Multiples-Based Value

The Multiples-Based Value of one ATRY stock under the Base Case scenario is hidden EUR. Compared to the current market price of 2.71 EUR, Atrys Health SA is hidden .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Multiples-Based Value calculated?

ATRY Multiples-Based Value

Unlock

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
ES	A	Atrys Health SA MAD:ATRY	207.9m EUR	0.9	-8.4	8.6	63.4
US		CVS Health Corp NYSE:CVS	89.1B USD	0.2	50.4	13.3	13.3
US	C	Cigna Group XMUN:CGN	66.9B EUR	0.3	13	7.7	9.7
US		Cigna Corp NYSE:CI	68B USD	0.2	11.4	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	25.1B EUR	1.1	19.9	9.4	14
DE		Fresenius Medical Care AG XMUN:FME	22.5B EUR	1.1	23	8.9	16.5
US		Laboratory Corporation of America Holdings NYSE:LH	21.7B USD	1.6	24.7	11.9	17.2
US		Quest Diagnostics Inc NYSE:DGX	21.7B USD	2	22	11.9	16
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.9B EUR	0.6	11.1	5.3	9.9
US		Guardant Health Inc NASDAQ:GH	11.3B USD	11.5	-27.1	-29.6	-26.9
US		DaVita Inc NYSE:DVA	10.4B USD	0.8	14	7.2	9.8

				Revenue Growth	P/S to Growth
ES	A	Atrys Health SA MAD:ATRY	Average P/S: 1.8 0.9	-1%	N/A
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.2	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.1	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	2	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	3%	0.2
US		Guardant Health Inc NASDAQ:GH	11.5	29%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2

				Earnings Growth	PEG
ES	A	Atrys Health SA MAD:ATRY	Average P/E: 21.1 Negative Multiple: -8.4	N/A	N/A
US		CVS Health Corp NYSE:CVS	50.4	90%	0.6
US	C	Cigna Group XMUN:CGN	13	19%	0.7
US		Cigna Corp NYSE:CI	11.4	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.9	26%	0.8
DE		Fresenius Medical Care AG XMUN:FME	23	16%	1.4
US		Laboratory Corporation of America Holdings NYSE:LH	24.7	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	22	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.1	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -27.1	N/A	N/A
US		DaVita Inc NYSE:DVA	14	20%	0.7

				EBITDA Growth	EV/EBITDA to Growth
ES	A	Atrys Health SA MAD:ATRY	Average EV/EBITDA: 9.4 8.6	9%	1
US		CVS Health Corp NYSE:CVS	13.3	28%	0.5
US	C	Cigna Group XMUN:CGN	7.7	4%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.4	10%	0.9
DE		Fresenius Medical Care AG XMUN:FME	8.9	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	11.9	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	11.9	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.3	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -29.6	N/A	N/A
US		DaVita Inc NYSE:DVA	7.2	4%	1.8

				EBIT Growth	EV/EBIT to Growth
ES	A	Atrys Health SA MAD:ATRY	Average EV/EBIT: 18.9 63.4	44%	1.4
US		CVS Health Corp NYSE:CVS	13.3	22%	0.6
US	C	Cigna Group XMUN:CGN	9.7	5%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	14	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	16.5	11%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	17.2	18%	1
US		Quest Diagnostics Inc NYSE:DGX	16	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.9	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -26.9	N/A	N/A
US		DaVita Inc NYSE:DVA	9.8	5%	2

Atrys Health SA
MAD:ATRY

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

ATRY Competitors Multiples
Atrys Health SA Competitors

See Also

Company

Help

Tools

Stocks

Atrys Health SA MAD:ATRY

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

ATRY Competitors Multiples Atrys Health SA Competitors

See Also

Company

Help

Tools

Stocks

Atrys Health SA
MAD:ATRY

ATRY Competitors Multiples
Atrys Health SA Competitors